| scholarly article | Q13442814 |
| P50 | author | Elliott D. Kieff | Q43399614 |
| Marc Vidal | Q81911349 | ||
| Eric Johannsen | Q88974235 | ||
| Tomoko Hirozane-Kishikawa | Q28914653 | ||
| Alexei Vazquez | Q29998806 | ||
| P2093 | author name string | Ning Li | |
| David E Hill | |||
| Michael A Calderwood | |||
| Li Xing | |||
| Amy M Holthaus | |||
| Michael R Chase | |||
| Kavitha Venkatesan | |||
| Alexandra E Ewence | |||
| P2860 | cites work | A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway | Q21735927 |
| Towards a proteome-scale map of the human protein–protein interaction network | Q21735930 | ||
| Scale-free networks in cell biology | Q22306161 | ||
| A human protein-protein interaction network: a resource for annotating the proteome | Q24324450 | ||
| Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100 | Q24336304 | ||
| Identification of an Epstein-Barr virus-coded thymidine kinase | Q24531739 | ||
| DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions | Q24548456 | ||
| Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator | Q24552333 | ||
| Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression | Q24562972 | ||
| Global topological features of cancer proteins in the human interactome | Q24672981 | ||
| Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module | Q24675538 | ||
| Emergence of Scaling in Random Networks | Q27037290 | ||
| Identification of p53 regulators by genome-wide functional analysis | Q37073614 | ||
| The essential protein encoded by the UL31 gene of herpes simplex virus 1 depends for its stability on the presence of UL34 protein | Q37269982 | ||
| EBNA2 is required for protection of latently Epstein-Barr virus-infected B cells against specific apoptotic stimuli. | Q37596895 | ||
| Proteins of purified Epstein-Barr virus | Q37621844 | ||
| Virion proteins of Kaposi's sarcoma-associated herpesvirus | Q37744006 | ||
| Herpesviral protein networks and their interaction with the human proteome | Q40341630 | ||
| Marked variation in response of consensus binding elements for the Rta protein of Epstein-Barr virus | Q40398044 | ||
| Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina. | Q40454370 | ||
| The Epstein-Barr virus BFRF1 and BFLF2 proteins interact and coexpression alters their cellular localization | Q40581794 | ||
| Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. | Q40585890 | ||
| A Noncanonical Poly(A) Signal, UAUAAA, and Flanking Elements in Epstein–Barr Virus DNA Polymerase mRNA Function in Cleavage and Polyadenylation Assays | Q41098863 | ||
| The genome of Epstein-Barr virus type 2 strain AG876. | Q45419603 | ||
| Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells | Q45482113 | ||
| Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa | Q45781476 | ||
| The herpes simplex virus type 1 ribonucleotide reductase is a tight complex of the type alpha 2 beta 2 composed of 40K and 140K proteins, of which the latter shows multiple forms due to proteolysis | Q45835381 | ||
| Purification and characterization of the herpes simplex virus type 1 ribonucleotide reductase small subunit following expression in Escherichia coli | Q45864240 | ||
| Ca++-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin | Q57374935 | ||
| Effect of sampling on topology predictions of protein-protein interaction networks | Q58067825 | ||
| Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene | Q83228685 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| The proteasome regulatory particle alters the SAGA coactivator to enhance its interactions with transcriptional activators. | Q27935912 | ||
| Protein interaction mapping in C. elegans using proteins involved in vulval development | Q28141447 | ||
| Development of human protein reference database as an initial platform for approaching systems biology in humans | Q28206967 | ||
| The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family | Q28307399 | ||
| Increased expression of rat ribosomal protein L4 mRNA in 5-azacytidine-treated PC12 cells prior to apoptosis | Q28569566 | ||
| The B cell receptor promotes B cell activation and proliferation through a non-ITAM tyrosine in the Igalpha cytoplasmic domain | Q28585554 | ||
| Lethality and centrality in protein networks | Q29547267 | ||
| Evidence for dynamically organized modularity in the yeast protein-protein interaction network | Q29614449 | ||
| BIND: the Biomolecular Interaction Network Database | Q29616859 | ||
| Hierarchical organization of modularity in metabolic networks | Q29618451 | ||
| MINT: a Molecular INTeraction database | Q29618559 | ||
| High-throughput yeast two-hybrid assays for large-scale protein interaction mapping | Q30992083 | ||
| The interacting UL31 and UL34 gene products of pseudorabies virus are involved in egress from the host-cell nucleus and represent components of primary enveloped but not mature virions | Q31032273 | ||
| P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus. | Q33292267 | ||
| The Epstein-Barr Virus (EBV) SM Protein Enhances Pre-mRNA Processing of the EBV DNA Polymerase Transcript | Q33785161 | ||
| U(L)31 and U(L)34 proteins of herpes simplex virus type 1 form a complex that accumulates at the nuclear rim and is required for envelopment of nucleocapsids | Q33854765 | ||
| Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical | Q33911878 | ||
| Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis | Q34154616 | ||
| Identification of proteins associated with murine gammaherpesvirus 68 virions | Q34226761 | ||
| Homer-3 regulates activation of serum response element in T cells via its EVH1 domain | Q34279743 | ||
| The Herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32. | Q34355898 | ||
| The MIPS mammalian protein-protein interaction database | Q34365947 | ||
| Identification of potential interaction networks using sequence-based searches for conserved protein-protein interactions or "interologs". | Q35037874 | ||
| Genome-wide analysis of vaccinia virus protein-protein interactions | Q35700178 | ||
| Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa | Q35839108 | ||
| The Epstein–Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression | Q36224577 | ||
| Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. | Q36682530 | ||
| Identification of new protein kinase-related genes in three herpesviruses, herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus | Q36780393 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| virus | Q808 | ||
| virology | Q7215 | ||
| P304 | page(s) | 7606-11 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Epstein-Barr virus and virus human protein interaction maps | |
| P478 | volume | 104 |
| Q30630727 | A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis |
| Q34871356 | A comparative approach to characterize the landscape of host-pathogen protein-protein interactions. |
| Q31135806 | A high-throughput yeast two-hybrid protocol to determine virus-host protein interactions |
| Q34342104 | A meta-analysis reveals the commonalities and differences in Arabidopsis thaliana response to different viral pathogens |
| Q24337769 | A physical interaction network of dengue virus and human proteins |
| Q28085616 | A review on computational systems biology of pathogen-host interactions |
| Q38836609 | A review on host-pathogen interactions: classification and prediction. |
| Q34945388 | A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication |
| Q37855296 | A systems biology perspective on plant–microbe interactions: Biochemical and structural targets of pathogen effectors |
| Q28535207 | A viral-human interactome based on structural motif-domain interactions captures the human infectome |
| Q37263197 | Aberrant LncRNA Expression Profile in a Contusion Spinal Cord Injury Mouse Model |
| Q27681995 | Allosteric competitive inactivation of hematopoietic CSF-1 signaling by the viral decoy receptor BARF1 |
| Q36062461 | An Epstein-Barr Virus-Encoded Protein Complex Requires an Origin of Lytic Replication In Cis to Mediate Late Gene Transcription |
| Q34551462 | An RS motif within the Epstein-Barr virus BLRF2 tegument protein is phosphorylated by SRPK2 and is important for viral replication |
| Q24614360 | An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions |
| Q24294710 | An integrated approach to elucidate the intra-viral and viral-cellular protein interaction networks of a gamma-herpesvirus |
| Q28834024 | An inter-species protein-protein interaction network across vast evolutionary distance |
| Q39529869 | Application of a split luciferase complementation assay for the detection of viral protein-protein interactions |
| Q28481666 | Associations between HIV and human pathways revealed by protein-protein interactions and correlated gene expression profiles |
| Q36180229 | BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV |
| Q55040933 | Beyond degree and betweenness centrality: Alternative topological measures to predict viral targets. |
| Q55278652 | CAGE-seq analysis of Epstein-Barr virus lytic gene transcription: 3 kinetic classes from 2 mechanisms. |
| Q38991952 | CCHCR1 interacts with EDC4, suggesting its localization in P-bodies. |
| Q34539656 | Chapter 4: Protein Interactions and Disease |
| Q36246186 | Characterization and intracellular trafficking of Epstein-Barr virus BBLF1, a protein involved in virion maturation |
| Q91623567 | Co-evolution of sites under immune selection shapes Epstein-Barr Virus population structure |
| Q39015802 | Comparative interactomics for virus-human protein-protein interactions: DNA viruses versus RNA viruses |
| Q37243867 | Comparative pathobiology of macaque lymphocryptoviruses |
| Q33959989 | Comparative pathogenesis and systems biology for biodefense virus vaccine development |
| Q34082740 | Computational Prediction of Host-Parasite Protein Interactions between P. falciparum and H. sapiens |
| Q38023077 | Computational analysis of interactomes: current and future perspectives for bioinformatics approaches to model the host-pathogen interaction space. |
| Q38564156 | Computational analysis of protein interaction networks for infectious diseases. |
| Q42272801 | Computational analysis of virus-host interactomes. |
| Q41838244 | Computational design of host transcription-factors sets whose misregulation mimics the transcriptomic effect of viral infections |
| Q27321686 | Computational discovery of Epstein-Barr virus targeted human genes and signalling pathways |
| Q41848439 | Concept and application of a computational vaccinology workflow |
| Q37562514 | Connecting viral with cellular interactomes |
| Q90424140 | Conserved Central Intraviral Protein Interactome of the Herpesviridae Family |
| Q91770815 | Conserved Herpesvirus Protein Kinases Target SAMHD1 to Facilitate Virus Replication |
| Q35660314 | Conserved herpesvirus kinases target the DNA damage response pathway and TIP60 histone acetyltransferase to promote virus replication. |
| Q34393261 | Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma |
| Q37428842 | Construction and application of a protein interaction map for white spot syndrome virus (WSSV). |
| Q35057277 | Construction and identification of a cDNA library for use in the yeast two-hybrid system from duck embryonic fibroblast cells post-infected with duck enteritis virus |
| Q37173042 | Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets |
| Q99710808 | Cross-regulation of viral kinases with cyclin A secures shutoff of host DNA synthesis |
| Q30597648 | Data-warehousing of protein-protein interactions indicates that pathogens preferentially target hub and bottleneck proteins |
| Q49834507 | Defining Pharmacological Targets by Analysis of Virus-Host Protein Interactions. |
| Q40011084 | Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles |
| Q33807905 | Dengue-2 structural proteins associate with human proteins to produce a coagulation and innate immune response biased interactome |
| Q33820396 | Detecting protein-protein interactions in vesicular stomatitis virus using a cytoplasmic yeast two hybrid system |
| Q38931276 | Discovering Protein-Protein Interactions Using Nucleic Acid Programmable Protein Arrays. |
| Q33961484 | Domain-domain interactions underlying herpesvirus-human protein-protein interaction networks |
| Q48193607 | Down-regulation of increased TRAF6 expression in the peripheral mononuclear cells of patients with primary Sjögren's syndrome by an EBV-EBER1-specific synthetic single-stranded complementary DNA molecule. |
| Q40518920 | Dynamics of Epstein-Barr viral load after hematopoietic stem cell transplantation and effect of preemptive rituximab therapy |
| Q38597233 | EBNA2 and Its Coactivator EBNA-LP. |
| Q84233061 | Electrochemical and Spectroscopic Studies on the Conformational Structure of Hemoglobin Assembled on Gold Nanoparticles |
| Q40083777 | Elucidation of host-pathogen protein-protein interactions to uncover mechanisms of host cell rewiring. |
| Q38257974 | Epstein- Barr Virus: Clinical and Epidemiological Revisits and Genetic Basis of Oncogenesis |
| Q39680157 | Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization |
| Q33900772 | Epstein-Barr virus infection of polarized epithelial cells via the basolateral surface by memory B cell-mediated transfer infection. |
| Q38603533 | Epstein-Barr virus latency: current and future perspectives |
| Q34115503 | Epstein-Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1 |
| Q36144801 | Epstein-Barr virus protein EB2 stimulates cytoplasmic mRNA accumulation by counteracting the deleterious effects of SRp20 on viral mRNAs |
| Q35014692 | Epstein–Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; Only the NTD interaction is essential for lymphoblastoid cell growth |
| Q21559419 | Evolutionarily conserved herpesviral protein interaction networks |
| Q63740135 | Experimental Analysis of Viral-Host Interactions |
| Q34305958 | Exploring the human diseasome: the human disease network |
| Q33749934 | Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification |
| Q28119098 | Flavivirus NS3 and NS5 proteins interaction network: a high-throughput yeast two-hybrid screen |
| Q40410439 | Fourier transform infrared spectroscopy on external perturbations inducing secondary structure changes of hemoglobin |
| Q37554932 | Functional roles of the tegument proteins of herpes simplex virus type 1. |
| Q33967454 | GPS-Prot: A web-based visualization platform for integrating host-pathogen interaction data |
| Q54318703 | Gene expression profile of campylobacter jejuni-induced GBS in bama miniature pigs |
| Q95779885 | Gene network and pathway generation and analysis |
| Q35943838 | Genome-Wide Analysis of Epstein-Barr Virus Rta DNA Binding |
| Q33703278 | Global approaches to study protein-protein interactions among viruses and hosts |
| Q24300336 | Global landscape of HIV-human protein complexes |
| Q30668574 | Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes |
| Q37646908 | HLA-DQ β1 alleles associated with Epstein-Barr virus (EBV) infectivity and EBV gp42 binding to cells |
| Q37236340 | HVint: A Strategy for Identifying Novel Protein-Protein Interactions in Herpes Simplex Virus Type 1 |
| Q35999440 | Hepatitis C Virus Protein Interaction Network Analysis Based on Hepatocellular Carcinoma |
| Q24311906 | Hepatitis C virus infection protein network |
| Q37570980 | Herpesvirus assembly: an update |
| Q28662112 | Herpesviruses: latency and reactivation - viral strategies and host response |
| Q89259638 | High-Quality Yeast-2-Hybrid Interaction Network Mapping |
| Q38117580 | Histone Deacetylases in Herpesvirus Replication and Virus-Stimulated Host Defense |
| Q38019869 | History of protein-protein interactions: from egg-white to complex networks |
| Q26852062 | Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens |
| Q21245042 | Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses |
| Q36749291 | Hubba: hub objects analyzer--a framework of interactome hubs identification for network biology |
| Q37654728 | Human enterovirus 71 protein interaction network prompts antiviral drug repositioning |
| Q33377381 | Human immunodeficiency virus type 1, human protein interaction database at NCBI. |
| Q40008314 | Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus |
| Q28485040 | Identification of new protein interactions between dengue fever virus and its hosts, human and mosquito |
| Q104799974 | Identification of protein/mRNA network involving the PSORS1 locus gene CCHCR1 and the PSORS4 locus gene HAX1 |
| Q45393985 | Identification of structural protein-protein interactions of herpes simplex virus type 1. |
| Q40075056 | Improving the Understanding of Pathogenesis of Human Papillomavirus 16 via Mapping Protein-Protein Interaction Network |
| Q108126773 | In silico Analyses of Immune System Protein Interactome Network, Single-Cell RNA Sequencing of Human Tissues, and Artificial Neural Networks Reveal Potential Therapeutic Targets for Drug Repurposing Against COVID-19 |
| Q34998257 | Inactivation of intergenic enhancers by EBNA3A initiates and maintains polycomb signatures across a chromatin domain encoding CXCL10 and CXCL9 |
| Q38367812 | Independently evolved virulence effectors converge onto hubs in a plant immune system network |
| Q38498315 | Infection Strategies of Bacterial and Viral Pathogens through Pathogen-Human Protein-Protein Interactions |
| Q35671608 | Insight into Bacterial Virulence Mechanisms against Host Immune Response via the Yersinia pestis-Human Protein-Protein Interaction Network |
| Q38443626 | Integration of omic networks in a developmental atlas of maize. |
| Q99207927 | Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis |
| Q38799502 | Integrative genomic and proteomic analyses identifies glycerol-3-phosphate acyltransferase as a target of low-dose ionizing radiation in EBV infected-B cells |
| Q50612850 | Interaction and localization diversities of global and local hubs in human protein-protein interaction networks |
| Q37087513 | Interaction networks for systems biology |
| Q33740683 | Interactome analysis of longitudinal pharyngeal infection of cynomolgus macaques by group A Streptococcus |
| Q38010411 | Interactome mapping for analysis of complex phenotypes: Insights from benchmarking binary interaction assays |
| Q29615773 | Interactome networks and human disease |
| Q28117120 | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins |
| Q34286099 | Intraviral protein interactions of Chandipura virus. |
| Q56888557 | Investigating genetic-and-epigenetic networks, and the cellular mechanisms occurring in Epstein-Barr virus-infected human B lymphocytes via big data mining and genome-wide two-sided NGS data identification |
| Q37069828 | Kaposi's Sarcoma-Associated Herpesvirus Inhibitor of cGAS (KicGAS), Encoded by ORF52, Is an Abundant Tegument Protein and Is Required for Production of Infectious Progeny Viruses |
| Q34325506 | Large scale genotype comparison of human papillomavirus E2-host interaction networks provides new insights for e2 molecular functions |
| Q37802870 | Large-scale protein interactome mapping: strategies and opportunities |
| Q58198909 | Les facteurs de virulence ciblent des protéines clés de l’interactome de l’hôte |
| Q40460448 | Local Action with Global Impact: Highly Similar Infection Patterns of Human Viruses and Bacteriophages. |
| Q38953504 | Manipulation of the host cell membrane by human γ-herpesviruses EBV and KSHV for pathogenesis |
| Q35856479 | Mapping the Protein-Protein Interactome Networks Using Yeast Two-Hybrid Screens |
| Q92327692 | Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas |
| Q38104272 | Microfluidic large scale integration of viral–host interaction analysis |
| Q42180912 | Molecular principles of human virus protein-protein interactions |
| Q44898800 | Network Biology editorial 2013. |
| Q29547462 | Network medicine: a network-based approach to human disease |
| Q35118812 | Network representations of immune system complexity |
| Q37901985 | Network-based methods for human disease gene prediction |
| Q52347943 | New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma |
| Q38048394 | New horizons for antiviral drug discovery from virus–host protein interaction networks |
| Q34783879 | Novel Burkholderia mallei virulence factors linked to specific host-pathogen protein interactions. |
| Q30385012 | Novel insights into human respiratory syncytial virus-host factor interactions through integrated proteomics and transcriptomics analysis |
| Q28710346 | Omics strategies for revealing Yersinia pestis virulence |
| Q30649415 | PRIMOS: An Integrated Database of Reassessed Protein–Protein Interactions Providing Web-Based Access toIn SilicoValidation of Experimentally Derived Data |
| Q26995884 | Pathway mapping and development of disease-specific biomarkers: protein-based network biomarkers |
| Q28551996 | Phosphoproteomic Profiling Reveals Epstein-Barr Virus Protein Kinase Integration of DNA Damage Response and Mitotic Signaling |
| Q28284451 | Phosphotyrosine signaling proteins that drive oncogenesis tend to be highly interconnected |
| Q35686822 | Prediction of interactions between HIV-1 and human proteins by information integration. |
| Q38100239 | Progress in computational studies of host-pathogen interactions |
| Q37192108 | Protein array identification of substrates of the Epstein-Barr virus protein kinase BGLF4 |
| Q92751220 | Protein interactions and consensus clustering analysis uncover insights into herpesvirus virion structure and function relationships |
| Q37125547 | Protein networks in disease |
| Q59356289 | Protein-protein interactions of human viruses |
| Q30002405 | Protein-protein interactions: analysis and prediction |
| Q33920099 | Proteome changes of lungs artificially infected with H-PRRSV and N-PRRSV by two-dimensional fluorescence difference gel electrophoresis. |
| Q35610639 | Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses |
| Q36468283 | Proteomic approaches to the study of papillomavirus-host interactions. |
| Q28066910 | Proteomic approaches to uncovering virus-host protein interactions during the progression of viral infection |
| Q39203410 | Proteomics and integrative omic approaches for understanding host-pathogen interactions and infectious diseases. |
| Q34790639 | Purification and characterization of HIV-human protein complexes |
| Q34557179 | Recent Advances in the Pathobiology of Hodgkin's Lymphoma: Potential Impact on Diagnostic, Predictive, and Therapeutic Strategies |
| Q38041258 | Recent Insights into Plant–Virus Interactions through Proteomic Analysis |
| Q28077351 | Reconstruction and Application of Protein-Protein Interaction Network |
| Q38994872 | Recovery of an HMWP/hmwBP (pUL48/pUL47) complex from virions of human cytomegalovirus: subunit interactions, oligomer composition, and deubiquitylase activity |
| Q33606237 | Response of the mosquito protein interaction network to dengue infection |
| Q36812436 | Role of RNF4 in the Ubiquitination of Rta of Epstein-Barr Virus |
| Q37820386 | Role of tegument proteins in herpesvirus assembly and egress |
| Q41983297 | SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function. |
| Q35497604 | Shared Molecular Strategies of the Malaria Parasite P. falciparum and the Human Virus HIV-1 |
| Q35067211 | Signatures of pleiotropy, economy and convergent evolution in a domain-resolved map of human-virus protein-protein interaction networks. |
| Q28660142 | Stringent homology-based prediction of H. sapiens-M. tuberculosis H37Rv protein-protein interactions |
| Q46268393 | Structural host-microbiota interaction networks |
| Q35081470 | Structural principles within the human-virus protein-protein interaction network |
| Q38506592 | Structural similarity-based predictions of protein interactions between HIV-1 and Homo sapiens. |
| Q39381317 | Structure and Function of Viral Deubiquitinating Enzymes. |
| Q27008867 | Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review |
| Q59137850 | Structure-based mechanism of action of a viral poly(ADP-ribose) polymerase 1-interacting protein facilitating virus replication |
| Q84445640 | Studies on the binding behavior of prodigiosin with bovine hemoglobin by multi-spectroscopic techniques |
| Q41462456 | Studying coronavirus-host protein interactions |
| Q35100906 | Supervised learning and prediction of physical interactions between human and HIV proteins |
| Q47232023 | Systems Biology Modeling to Study Pathogen-Host Interactions |
| Q38647215 | Systems biology and the future of medicine |
| Q35189593 | Systems biology in immunology: a computational modeling perspective. |
| Q38063490 | Systems biology of pathogen‐host interaction: Networks of protein‐protein interaction within pathogens and pathogen‐human interactions in the post‐genomic era |
| Q38901833 | TLR3/TRIF signalling pathway regulates IL-32 and IFN-β secretion through activation of RIP-1 and TRAF in the human cornea |
| Q37685690 | Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions |
| Q38597236 | The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells |
| Q33870920 | The Enterococcus faecalis virulence factor ElrA interacts with the human Four-and-a-Half LIM Domains Protein 2 |
| Q35076801 | The Epstein-Barr Virus BRRF1 Protein, Na, Induces Lytic Infection in a TRAF2- and p53-Dependent Manner |
| Q37157230 | The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity. |
| Q39735571 | The Epstein-Barr virus (EBV)-encoded protein kinase, EBV-PK, but not the thymidine kinase (EBV-TK), is required for ganciclovir and acyclovir inhibition of lytic viral production |
| Q36845933 | The Epstein-Barr virus LF2 protein inhibits viral replication |
| Q42772702 | The HPV E2-Host Protein-Protein Interactions: A Complex Hijacking of the Cellular Network. |
| Q34497852 | The Hepatitis E virus intraviral interactome |
| Q34549700 | The Promise of Proteomics in the Study of Oncogenic Viruses |
| Q22061801 | The Protein Interaction Network of Bacteriophage Lambda with Its Host, Escherichia coli |
| Q35665740 | The Virion-Associated Open Reading Frame 49 of Murine Gammaherpesvirus 68 Promotes Viral Replication both In Vitro and In Vivo as a Derepressor of RTA |
| Q33937468 | The hubs of the human connectome are generally implicated in the anatomy of brain disorders |
| Q21136185 | The human-bacterial pathogen protein interaction networks of Bacillus anthracis, Francisella tularensis, and Yersinia pestis |
| Q28115759 | The interactomes of influenza virus NS1 and NS2 proteins identify new host factors and provide insights for ADAR1 playing a supportive role in virus replication |
| Q33320187 | The landscape of human proteins interacting with viruses and other pathogens |
| Q38574687 | The long-lasting love affair between the budding yeast Saccharomyces cerevisiae and the Epstein-Barr virus |
| Q37209104 | The social network of a cell: recent advances in interactome mapping |
| Q26865799 | Toward a systems understanding of plant-microbe interactions |
| Q36482177 | Toward a three-dimensional view of protein networks between species |
| Q28703601 | Turning gold into 'junk': transposable elements utilize central proteins of cellular networks |
| Q64064525 | Understanding Human-Virus Protein-Protein Interactions Using a Human Protein Complex-Based Analysis Framework |
| Q34059171 | Uracil DNA glycosylase BKRF3 contributes to Epstein-Barr virus DNA replication through physical interactions with proteins in viral DNA replication complex. |
| Q42215545 | Use of host-like peptide motifs in viral proteins is a prevalent strategy in host-virus interactions |
| Q30869213 | VirHostNet 2.0: surfing on the web of virus/host molecular interactions data |
| Q24656219 | VirHostNet: a knowledge base for the management and the analysis of proteome-wide virus-host interaction networks |
| Q33688106 | Viral Organization of Human Proteins |
| Q34325431 | Viral perturbations of host networks reflect disease etiology |
| Q42208218 | Viral proteins that bridge unconnected proteins and components in the human PPI network |
| Q36032647 | Viral-Host Protein Interaction Studies Using Yeast Two-Hybrid Screening Method |
| Q27490817 | ViralORFeome: an integrated database to generate a versatile collection of viral ORFs |
| Q36594106 | Virion-wide protein interactions of Kaposi's sarcoma-associated herpesvirus |
| Q36125256 | Virus interactions with human signal transduction pathways |
| Q30378653 | Virus-host interactions: from systems biology to translational research |
| Q28652236 | Virus-host interactomics: new insights and opportunities for antiviral drug discovery |
| Q42234001 | Viruses and interactomes in translation |
| Q33799911 | When the human viral infectome and diseasome networks collide: towards a systems biology platform for the aetiology of human diseases. |
| Q24300877 | Xeroderma pigmentosum C is involved in Epstein Barr virus DNA replication |
| Q33869574 | Yeast two hybrid analyses reveal novel binary interactions between human cytomegalovirus-encoded virion proteins. |
Search more.